Stratifying hypoglycaemic event risk in insulin-treated diabetes
The potential of individuals with diabetes to develop hypoglycaemia during insulin treatment presents a possible risk to them and others in certain safety-critical tasks, such as driving. Restrictions for insulin-treated drivers may limit this risk, but the evidence upon which such restrictions are based is limited. Prior epidemiological and pathophysiological evidence suggests that individuals with Type 2 diabetes in the early stages of insulin treatment may be: 1. at no greater risk of hypoglycaemia than individuals with Type 2 diabetes treated with sulphonylureas; 2. prone to less severe or less frequent periods of hypoglycaemia compared people with Type 1 diabetes. A prospective study, measuring the frequency and type of hypoglycaemia in different groups of individuals with diabetes was conducted to test these two hypotheses. This study used self-reported hypoglycaemia (measured by questionnaires) and continuous glucose monitoring to record episodes of hypoglycaemia over 9-12 months for people with both Type 1 and Type 2 diabetes.
- Record URL:
-
Availability:
- Find a library where document is available. Order URL: http://worldcat.org/isbn/190476357X
-
Corporate Authors:
Great Britain. Department for Transport
London, -
Authors:
- Heller, S
- Publication Date: 2006-3
Language
- English
Media Info
- Pagination: 70p
-
Serial:
- Issue Number: 61
Subject/Index Terms
- TRT Terms: Diseases and medical conditions; Driver licenses; Driver performance; Drug effects; Highway safety; Impaired drivers; Medical treatment; Medication
- Uncontrolled Terms: Road safety (human factors)
- Geographic Terms: United Kingdom
- ATRI Terms: Driver performance; Drivers licence; Drug effects; Fitness to drive; Illness; Medical treatment; Medication; Road safety
- Subject Areas: Safety and Human Factors;
Filing Info
- Accession Number: 01388760
- Record Type: Publication
- Source Agency: ARRB
- ISBN: 190476357X
- Files: ATRI
- Created Date: Aug 23 2012 1:16AM